Insider Buying: Solesence (NASDAQ:SLSN) Director Purchases 10,000 Shares of Stock

Solesence, Inc. (NASDAQ:SLSNGet Free Report) Director R Janet Whitmore acquired 10,000 shares of the stock in a transaction dated Wednesday, November 19th. The shares were bought at an average cost of $1.92 per share, with a total value of $19,200.00. Following the completion of the purchase, the director directly owned 2,084,198 shares in the company, valued at approximately $4,001,660.16. This trade represents a 0.48% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

R Janet Whitmore also recently made the following trade(s):

  • On Tuesday, November 18th, R Janet Whitmore purchased 267 shares of Solesence stock. The shares were acquired at an average cost of $1.83 per share, with a total value of $488.61.
  • On Monday, November 17th, R Janet Whitmore purchased 5,000 shares of Solesence stock. The shares were purchased at an average cost of $1.87 per share, with a total value of $9,350.00.
  • On Friday, November 14th, R Janet Whitmore bought 19,789 shares of Solesence stock. The shares were acquired at an average price of $1.73 per share, with a total value of $34,234.97.

Solesence Stock Down 3.6%

Shares of Solesence stock traded down $0.08 during trading on Thursday, reaching $2.13. The company had a trading volume of 34,231 shares, compared to its average volume of 91,233. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.78 and a current ratio of 1.84. Solesence, Inc. has a fifty-two week low of $1.34 and a fifty-two week high of $16.56. The firm’s fifty day moving average is $2.91 and its 200-day moving average is $3.48. The company has a market cap of $150.25 million, a price-to-earnings ratio of 213.21 and a beta of 1.07.

Solesence (NASDAQ:SLSNGet Free Report) last announced its quarterly earnings data on Thursday, November 13th. The company reported ($0.02) earnings per share for the quarter. The business had revenue of $14.60 million for the quarter. Solesence had a net margin of 1.72% and a return on equity of 6.53%.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Solesence in a research note on Monday. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Solesence presently has a consensus rating of “Sell”.

Get Our Latest Stock Report on Solesence

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Bank of America Corp DE acquired a new position in Solesence during the second quarter valued at approximately $26,000. Police & Firemen s Retirement System of New Jersey acquired a new position in Solesence during the second quarter worth about $29,000. JPMorgan Chase & Co. acquired a new position in shares of Solesence during the second quarter worth $39,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in Solesence in the second quarter valued at about $45,000. Finally, Intech Investment Management LLC bought a new stake in Solesence during the 2nd quarter worth approximately $46,000. Institutional investors and hedge funds own 70.22% of the company’s stock.

About Solesence

(Get Free Report)

Nanophase Technologies Corporation provides engineered materials, formulation development, and commercial manufacturing with an integrated family of technologies in the United States. It offers surface engineered zinc oxide and titanium dioxide for sunscreens and personal care products; fully formulated cosmetics, sun care, and skin care under the Solésence brand name; and advanced materials products, such as architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and various surface finishing technologies applications.

Featured Stories

Receive News & Ratings for Solesence Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solesence and related companies with MarketBeat.com's FREE daily email newsletter.